Log In
BCIQ
Print this Print this
 

SI-613

  Manage Alerts
Collapse Summary General Information
Company Seikagaku Corp.
DescriptionFormulation of hyaluronic acid and a non-steroidal anti-inflammatory drug (NSAID)
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today